[Effect of inhibition of telomerase activity on cisplatin-induced apoptosis in K562 cells].
Dalin He, H Zhang
Abstract
Dalin He, H Zhang
Abstract
OBJECTIVE: To explore the effect of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) on telomerase activity and cisplatin-induced apoptosis in K562 cells. METHODS: Telomerase activity was analyzed by using polymerase chain reaction enzyme-linked immunoassay (PCR-ELISA), expression levels of hTERT protein by immunofluorescence and apoptosis by DNA gel electrophoresis and flow cytometry. RESULTS: There was a marked decrease in both the percentage of hTERT protein positive cells and the telomerase activity in ASODN treated cell as compared with that in control and sense oligodeoxynucleotide (SODN)-treated cells; but no difference between the latter two groups. Agarose gel electrophoresis of genomic DNA from K562 cells treated with ASODN and cisplatin combination for 72 h showed typical DNA ladder; neither did DNA from K562 cells treated with SODN plus cisplatin nor cisplatin alone. Apoptosis rates of K562 cells treated with ASODN for 24 h and then with cisplatin for 72 h were significantly increased. There was statistically significant difference in the percentage of apoptotic cells between hTERT ASODN plus cisplatin group and SODN plus cisplatin or cisplatin alone group. CONCLUSION: The hTERT gene ASODN could inhibit telomerase activity of K562 cells whereby it enhanced cisplatin-induced apoptosis of the cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To explore the effect of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) on telomerase activity and cisplatin-induced apoptosis in K562 cells. METHODS: Telomerase activity was analyzed by using polymerase chain reaction enzyme-linked immunoassay (PCR-ELISA), expression levels of hTERT protein by immunofluorescence and apoptosis by DNA gel electrophoresis and flow cytometry. RESULTS: There was a marked decrease in both the percentage of hTERT protein positive cells and the telomerase activity in ASODN treated cell as compared with that in control and sense oligodeoxynucleotide (SODN)-treated cells; but no difference between the latter two groups. Agarose gel electrophoresis of genomic DNA from K562 cells treated with ASODN and cisplatin combination for 72 h showed typical DNA ladder; neither did DNA from K562 cells treated with SODN plus cisplatin nor cisplatin alone. Apoptosis rates of K562 cells treated with ASODN for 24 h and then with cisplatin for 72 h were significantly increased. There was statistically significant difference in the percentage of apoptotic cells between hTERT ASODN plus cisplatin group and SODN plus cisplatin or cisplatin alone group. CONCLUSION: The hTERT gene ASODN could inhibit telomerase activity of K562 cells whereby it enhanced cisplatin-induced apoptosis of the cells.
Key concepts: Cisplatin, Telomerase, Telomerase reverse transcriptase, Molecular biology, Apoptosis, K562 cells, Agarose gel electrophoresis, Flow cytometry